Partenaires
Transgene
Transgene is a biopharmaceutical company dedicated to the discovery and development of gene-based therapeutic vaccines and immunotherapy products for the treatment of cancer and infectious diseases.

Transgene's business strategy is based on its broad technology platform for gene delivery. Transgene implements this strategy in three different ways :
- by developing vaccines and products in specific indications and partnering with pharmaceutical companies for later stage development ;
- by independently developing and commercializing vaccines and products for certain special markets ;
- by licensing vector technologies to companies with proprietary genes for short and medium term revenues.
Discover www.transgene.fr/
18/11/2008
Alps Bio Cluster: first European transalpin biotech and medtech network![]()
24/10/2008
The second edition of the Lyonbiopôle Partnering Days achieved a great success![]()
22/10/2008
ADNA program receives approval from the European Commission up to € 90M![]()
08/10/2008
Projects of Partnership between Lyonbiopôle and BioWin shape at EuroBio Paris![]()











